Skip to main content

Table 3 Medications with decreased consumption found in the number of people in the IG

From: Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

 

Number of people taking medications

Difference

Percentage

Generic name

A. 2019

B. 2020

C. A-B

C/A

Magnesium Oxidea

118

43

75

63.6%

Furosemidea

57

40

17

29.8%

Spironolactonea

41

25

16

39.0%

Sennoside

41

28

13

31.7%

White Vaseline

17

5

12

70.6%

Butyric acid bacteria

24

13

11

45.8%

Amlodipine

57

47

10

17.5%

Dimethylisopropyl azulene

15

5

10

66.7%

Famotidinea

13

3

10

76.9%

Azithromycin

9

0

9

100.0%

Ambroxol

11

2

9

81.8%

Ketoprofena

13

4

9

69.2%

Loxoprofena

16

7

9

56.3%

Liver-Inhibiting Powder plus Tangerine Peel, Pinellia Tuber

9

0

9

100.0%

Oseltamivir

8

0

8

100.0%

  1. a Generic name listed in “Guidelines for medical treatment and its safety in older people 2015”
  2. IG (improvement group), the participants who were prescribed PIMs in March 2019 and those who were not prescribed PIMs in March 2020
  3. The study period was between March 2019 and March 2020